Acute myeloid leukemia( AML ) is a clonal and heterogeneous disease characterized by a myriad of genetic defects. 急性髓性白血病 ( acutemyeloid leukemia, AML ) 是一类起源于造血干细胞的、以大量遗传缺陷为特征的异质性恶性血液病. 互联网 Methods: Induction regiment ofacute myeloid leukemia( AML ) co...
Acute myeloid leukemia 青云英语翻译 请在下面的文本框内输入文字,然后点击开始翻译按钮进行翻译,如果您看不到结果,请重新翻译! 翻译结果1翻译结果2翻译结果3翻译结果4翻译结果5 翻译结果1复制译文编辑译文朗读译文返回顶部 急性髓细胞性白血病 翻译结果2复制译文编辑译文朗读译文返回顶部...
[translate] awooden lie 木谎言[translate] aacute myeloid leukemia, myelodysplasia, renal, gastric, prostate and other solid tissue tumors 急性骨髓状白血病, myelodysplasia,肾脏,胃,摄护腺和其他坚实组织肿瘤[translate]
Acute Myeloid Leukemia ( AML )Differentiation, Impaired
急性髓系白血病(Acute myeloid leukemia, AML)是最常见的白血病类型之一,且难以治愈。AML的特征在于快速增长的异常细胞,积聚在骨髓和血液中,进而干扰正常血细胞。其症状包括感到疲倦,呼吸急促,容易瘀伤和出血以及感染风险增加。AML的进展较为迅速,如果不及时治疗,通常会有生命危险。
Acute myeloid leukemia (AML) is a cancer that starts in the cells of your bone marrow that make different types of blood cells. It usually starts in a precursor cell to one type of white blood cell. Many of the symptoms of AML are nonspecific, which means they can be caused by several...
Related to acute myeloid leukemia:Chronic Myeloid Leukemia ThesaurusAntonymsRelated WordsSynonymsLegend: Switch tonew thesaurus Noun1. acute myeloid leukemia- acute leukemia characterized by proliferation of granular leukocytes; most common in adolescents and young adults ...
[1]. Acute myeloid leukemia (AML) is considered acute because it progresses quickly if no suitable intervention is found, and can be very fatal in a short period[2][3,4]. Acute myeloid leukemia (AML) is reported to account for roughly 1.2% of cancer deaths in the United States although...
(D9) Differentiation of blast cells in MDS and acute myeloid leukemia by automated image analysis Baumann I., Harms H.∗, Wilms K.∗∗, Zwierzina H.∗∗∗, Kuse R., Mueiller-Hermelink, H.K., Institute of Pathology, Institute of Virology∗, Med. Poliklinik∗∗ Universit...
Cancer vaccines are promising treatments to prevent relapse after chemotherapy in acute myeloid leukemia (AML) patients, particularly for those who cannot tolerate intensive consolidation therapies. Here, we report the development of an AML cell membrane-coated nanoparticle (AMCNP) vaccine platform, in ...